Back to mobile site

Cantor Fitzgerald Starts Codexis (CDXS) at Buy; Enabling Pharma/Fuels Enzymes

June 9, 2010 7:40 AM EDT Send to a Friend
Cantor Fitzgerald initiates coverage on Codexis, Inc. (Nasdaq: CDXS) with a Buy rating. PT $13.

The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login